Literature DB >> 33532140

Mechanism of Ferroptosis: A Potential Target for Cardiovascular Diseases Treatment.

Jie Ju1, Ya-Nan Song2, Kun Wang1.   

Abstract

Ferroptosis is a form of programmed cell death caused by production of reactive oxygen species and disequilibrium of iron homeostasis. Many chemical compounds and clinical drugs induce ferroptosis in normal and cancer cells, while peroxidation inhibitors, iron chelators, and antioxidants can block ferroptosis. Glutathione peroxidase 4, ferroptosis suppressor protein 1, nuclear factor erythroid 2-related factor 2, and system Xc- are the negative regulators of ferroptosis, whereas nicotinamide adenine dinucleotide phosphate oxidase, p53, mitochondria voltage-dependent anion channel, and cysteinyl-tRNA synthetase function as positive regulators. Ferroptosis plays important roles in pathogen infection and tumor immunology. Recent studies suggest that ferroptosis plays a vital role in the pathogenesis of cardiovascular diseases (CVDs), which seriously threaten human health. Potential therapies designed around ferroptosis may alter the pathological progression of CVDs. Therefore, we redacted an overview of the discovery of ferroptosis, its regulatory mechanisms, and its potential impact on CVDs treatment. copyright:
© 2021 Ju et al.

Entities:  

Keywords:  cardiovascular diseases; ferroptosis; iron; reactive oxygen species

Year:  2021        PMID: 33532140      PMCID: PMC7801281          DOI: 10.14336/AD.2020.0323

Source DB:  PubMed          Journal:  Aging Dis        ISSN: 2152-5250            Impact factor:   6.745


  9 in total

Review 1.  Extracellular vesicles, a novel model linking bacteria to ferroptosis in the future?

Authors:  Yi Li; Zhicheng Guo; Tian Xu; Yejia Zhang; Lingbing Zeng; Xiaotian Huang; Qiong Liu
Journal:  Appl Microbiol Biotechnol       Date:  2022-10-11       Impact factor: 5.560

2.  MiR-27a-3p Promotes Non-Small Cell Lung Cancer Through SLC7A11-Mediated-Ferroptosis.

Authors:  Xuan Lu; Ningning Kang; Xinxin Ling; Ming Pan; Wenjing Du; Shan Gao
Journal:  Front Oncol       Date:  2021-10-13       Impact factor: 6.244

Review 3.  Regulation of Ferroptosis by Amino Acid Metabolism in Cancer.

Authors:  Jian Yang; Xinyu Dai; Huanji Xu; Qiulin Tang; Feng Bi
Journal:  Int J Biol Sci       Date:  2022-02-07       Impact factor: 6.580

Review 4.  Insights Into Ferroptosis, a Novel Target for the Therapy of Cancer.

Authors:  Hong-Tao Wang; Jie Ju; Shao-Cong Wang; Yu-Hui Zhang; Cui-Yun Liu; Tao Wang; Xue Yu; Fei Wang; Xue-Ru Cheng; Kun Wang; Zhao-Yang Chen
Journal:  Front Oncol       Date:  2022-02-25       Impact factor: 6.244

Review 5.  Ferroptosis as a Novel Therapeutic Target for Diabetes and Its Complications.

Authors:  Xi-Ding Yang; Yong-Yu Yang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-29       Impact factor: 5.555

6.  Counteraction of Myocardial Ferritin Heavy Chain Deficiency by Heme Oxygenase-1.

Authors:  Sarah E Machado; Daryll Spangler; Delores A Stacks; Victor Darley-Usmar; Gloria A Benavides; Min Xie; József Balla; Abolfazl Zarjou
Journal:  Int J Mol Sci       Date:  2022-07-27       Impact factor: 6.208

Review 7.  Oxidative Stress and Lipid Peroxidation: Prospective Associations Between Ferroptosis and Delayed Wound Healing in Diabetic Ulcers.

Authors:  Jiawei Feng; Jialin Wang; Yuqing Wang; Xiaoting Huang; Tengteng Shao; Xiaofei Deng; Yemin Cao; Mingmei Zhou; Cheng Zhao
Journal:  Front Cell Dev Biol       Date:  2022-07-08

Review 8.  Molecular mechanism of ferroptosis and its role in the occurrence and treatment of diabetes.

Authors:  Guanghui Du; Qi Zhang; Xiaobo Huang; Yi Wang
Journal:  Front Genet       Date:  2022-09-09       Impact factor: 4.772

Review 9.  Ferroptosis in Cardiovascular Diseases: Current Status, Challenges, and Future Perspectives.

Authors:  Yi Guo; Chanjun Lu; Ke Hu; Chuanqi Cai; Weici Wang
Journal:  Biomolecules       Date:  2022-03-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.